References
- Coronavirus&COVID-19 overview: symptoms,risks, prevention, treatment & more [Internet]. New York (NY): Webmd; c2024 [cited 2024 Jan 8]. Available from: https://www.webmd.com/covid/coronavirus
- COVID-19: epidemiology, virology, and prevention [Internet]. Waltham (MA): UpToDate; 2024 [cited 2024 Jan 8]. Available from: https://www.uptodate.com/contents/covid-19-epidemiology-virology-and-prevention
- COVID-19 Data Explorer [Internet]. Oxford: Our World in Data; 2024 [cited 2024 Jan 8]. Available from: https://ourworldindata.org/explorers/coronavirus-data-explorer
- Vaccines and Related Biological Products Advisory Committee December 10, 2020 Meeting Briefing Document-FDA[Internet]. Silver Spring (MD): Food and Drug Administration; 2020 [cited 2024 Jan 8]. Available from: https://www.fda.gov/media/144245
- NassarRI,Alnatour D, Thiab S, NassarA, El-Hajji F,Basheti IA. Short-term side effects of COVID-19 vaccines: a cross-sectional study in Jordan. Hum Vaccin Immunother 2022;18:2082792.
- Medeiros KS, Costa AP, Sarmento AC, Freitas CL, Goncalves AK. Side effects of COVID-19 vaccines: a systematic review and meta-analysis protocol of randomised trials. BMJ Open 2022;12:e050278.
- Ferguson D, Wrigley S, Purcell E, et al. Single center analysis of patients with H1N1 vaccine-related narcolepsy and sporadic narcolepsy presenting over the same time period. J Clin Sleep Med 2021;17:885-95. https://doi.org/10.5664/jcsm.9052
- Watson OJ, Barnsley G, ToorJ, HoganAB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis 2022;22:1293-302. https://doi.org/10.1016/S1473-3099(22)00320-6
- Selected adverse events reported after COVID-19 vaccination [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2023 [cited 2024 Jan 8]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/adverse-events.html
- El-Shitany NA, Harakeh S, Badr-Eldin SM, et al. Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: a retrospective cross-sectional study.Int J Gen Med 2021;14:1389-401. https://doi.org/10.2147/IJGM.S310497
- Mulligan MJ, Lyke KE, Kitchin N, et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature 2020;586:589-93. https://doi.org/10.1038/s41586-020-2639-4
- Mansukhani MP, Kolla BP, Ramar K. International classification of sleep disorders 2 and American Academy of Sleep Medicine practice parameters for central sleep apnea. Sleep MedClin2014;9:1-11.
- Bassetti CL, Adamantidis A, Burdakov D, et al. Narcolepsy: clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol 2019;15:519-39.
- Sarkanen TO, Alakuijala AP, Dauvilliers YA, Partinen MM. Incidence of narcolepsy after H1N1 influenza and vaccinations: systematic review and meta-analysis. Sleep Med Rev 2018;38:177-86. https://doi.org/10.1016/j.smrv.2017.06.006
- Nohynek H, Jokinen J, Partinen M, et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One 2012;7:e33536.
- Miller E, Andrews N, Stellitano L, et al. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. BMJ 2013;346:f794.
- Ahmed SS, Volkmuth W, Duca J, et al. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. Sci Transl Med 2015;7:294ra105.
- Garrido-Suarez BB, Garrido-Valdes M, Garrido G. Reactogenic sleepiness after COVID-19 vaccination: a hypothesis involving orexinergic system linked to inflammatory signals. Sleep Med 2022;98:79-86. https://doi.org/10.1016/j.sleep.2022.06.011
- Kelley KW, Kent S. The legacy of sickness behaviors. Front Psychiatry 2020;11:607269.
- Irwin MR, Opp MR. Sleep health: reciprocal regulation of sleep and innate immunity. Neuropsychopharmacology 2017;42:129-55. https://doi.org/10.1038/npp.2016.148
- Besedovsky L, Lange T, Haack M. The sleep-immune crosstalk in health and disease. Physiol Rev 2019;99:1325-80. https://doi.org/10.1152/physrev.00010.2018
- Chieffi S, Carotenuto M, Monda V, et al. Orexin system: the key for a healthy life. Front Physiol 2017;8:357.
- Di Pasquale A, Bonanni P, Garcon N, Stanberry LR, El-Hodhod M, Tavares Da Silva F. Vaccine safety evaluation: practical aspects in assessing benefits and risks. Vaccine 2016;34:6672-80. https://doi.org/10.1016/j.vaccine.2016.10.039
- Lange T, Dimitrov S, Bollinger T, Diekelmann S, Born J. Sleep after vaccination boosts immunological memory. J Immunol 2011;187:283-90. https://doi.org/10.4049/jimmunol.1100015
- Sleep deprivation and deficiency: what are sleep deprivation and deficiency? [Internet]. Bethesda (MD): National Heart, Lung, and Blood Institute; 2022 [cited 2024 Jan 8]. Available from: https://www.nhlbi.nih.gov/health/sleep-deprivation
- Borobia AM, Carcas AJ, Perez-Olmeda M, et al. Immunogenicity andreactogenicityofBNT162b2boosterinChAdOx1-S-primed participants (CombiVacS): a multicentre, openlabel, randomised, controlled, phase 2 trial. Lancet 2021;398:121-30. https://doi.org/10.1016/S0140-6736(21)01420-3
- Toledo-Romani ME, Garcia-Carmenate M, Verdecia-Sanchez L, et al. Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: phase IIb clinical trial in adults. Med 2022;3:760-73. https://doi.org/10.1016/j.medj.2022.08.001
- Hernandez-Bernal F, Ricardo-Cobas MC, Martin-Bauta Y, et al. Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: a randomised, double-blind, placebo-controlled, phase 1-2 clinical trial(ABDALA Study). EClinicalMedicine 2022;46:101383.
- Yamamoto S, Fukunaga A, Tanaka A, et al. Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine. Vaccine 2022;40:1924-7. https://doi.org/10.1016/j.vaccine.2022.02.052